Digirad Corporation (DRAD): Price and Financial Metrics


Digirad Corporation (DRAD)

Today's Latest Price: $3.13 USD

0.75 (31.51%)

Updated Jun 5 4:00pm

Add DRAD to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

DRAD Stock Summary

  • Digirad Corp's market capitalization of $4,891,276 is ahead of only 2.28% of US-listed equities.
  • The capital turnover (annual revenue relative to shareholder's equity) for DRAD is 6.71 -- better than 94.04% of US stocks.
  • DRAD's price/sales ratio is 0.04; that's higher than the P/S ratio of only 1.82% of US stocks.
  • Stocks that are quantitatively similar to DRAD, based on their financial statements, market capitalization, and price volatility, are RCMT, INWK, CCRN, BBBY, and BGG.
  • Visit DRAD's SEC page to see the company's official filings. To visit the company's web site, go to www.digirad.com.
DRAD Daily Price Range
DRAD 52-Week Price Range

DRAD Stock Price Chart More Charts


DRAD Price/Volume Stats

Current price $3.13 52-week high $8.84
Prev. close $2.38 52-week low $1.99
Day low $2.45 Volume 1,563,098
Day high $3.30 Avg. volume 312,657
50-day MA $2.97 Dividend yield N/A
200-day MA $3.48 Market Cap 6.56M

Digirad Corporation (DRAD) Company Bio


Digirad Corporation provides diagnostic solutions in the United States. The company operates in two segments, Diagnostic Services and Diagnostic Imaging. The company was founded in 1985 and is based in Suwanee, Georgia.


DRAD Latest News Stream


Event/TimeNews Detail
Loading, please wait...

DRAD Latest Social Stream


Loading social stream, please wait...

View Full DRAD Social Stream

Latest DRAD News From Around the Web

Below are the latest news stories about Digirad Corp that investors may wish to consider to help them evaluate DRAD as an investment opportunity.

Digirad Celebrates the 20th Anniversary of the First Commercially Performed Solid-state Nuclear Medicine Scan

SUWANEE, Ga.--(BUSINESS WIRE)-- #cardiology--Digirad celebrates the 20th anniversary of the first commercially performed solid-state nuclear medicine scan.

Business Wire | June 2, 2020

World Nuclear Medicine Imaging Equipment Market Analysis, Featuring Digirad Corporation, GE Healthcare, Mediso Medical Imaging Systems and Philips Healthcare

DUBLIN, May 28, 2020 /PRNewswire/ -- The "Nuclear Medicine Imaging Equipment - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis and the looming economic recession, the Nuclear Medicine Imaging Equipment market…

PR Newswire | May 28, 2020

Digirad Corporation Announces Closing of $5.0 Million Underwritten Public Offering

Digirad Corporation (Nasdaq: DRAD; DRADP) (“Digirad” or the “Company”), a diversified holding company with three operating divisions: healthcare, building and construction, and real estate and investments, today announced the closing of its previously announced underwritten public offering of 2,225,000 shares of its common stock and warrants to purchase up to 1,112,500 shares of the Company’s common stock (the “Common Warrants”). Each share of common stock was sold together with one common warrant to purchase 0.5 shares of common stock at a price of $2.25 per share and common warrant. In addition, Digirad granted to Maxim Group LLC, a 45-day option to purchase up to an additional 225,000 shares of common stock and/or 225,000 Common Warrants to purchase up to 112,500 shares of common s...

Yahoo | May 28, 2020

Digirad Corporation Announces Pricing of $5.0 Million Underwritten Public Offering

Digirad Corporation (Nasdaq: DRAD; DRADP) (“Digirad” or the “Company”), a diversified holding company with three operating divisions: healthcare, building and construction, and real estate and investments, today announced the pricing of an underwritten public offering of 2,225,000 shares of its common stock and warrants to purchase up to 1,112,500 shares of the Company’s common stock (the “common warrants”). Each share of common stock is being sold together with one common warrant to purchase 0.5 shares of common stock at a price of $2.25 per share and common warrant. The common warrants will be immediately exercisable at a price of $2.25 per share of common stock and will expire five years from the date of issuance.

Yahoo | May 26, 2020

Edited Transcript of DRAD earnings conference call or presentation 15-May-20 3:00pm GMT

Q1 2020 Digirad Corp Earnings Call

Yahoo | May 15, 2020

Read More 'DRAD' Stories Here

DRAD Price Returns

1-mo 9.44%
3-mo -54.24%
6-mo 11.39%
1-year -46.59%
3-year -91.07%
5-year -89.98%
YTD 20.38%
2019 -54.39%
2018 -75.95%
2017 -45.40%
2016 -10.09%
2015 38.79%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7423 seconds.